申请人:Hoechst Aktiengesellschaft
公开号:US04542127A1
公开(公告)日:1985-09-17
Salicylic acid derivatives of the formula I ##STR1## wherein R.sup.1, W, X, Y and Z have the meanings indicated or a physiologically tolerated salt thereof, processes for their preparation, pharmaceutical formulations based on these compounds and their use as antidiabetic agents.
公式I中的水杨酸衍生物 ##STR1## 其中R.sup.1,W,X,Y和Z具有所示的含义或其生理上可耐受的盐,制备这些化合物的过程,基于这些化合物的制药配方以及它们作为抗糖尿病药物的用途。